B

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Manager of Non-Conformance - Root Cause Analysis/Deviations

Validation, Compliance & Quality SystemsConfirmed live in the last 24 hours
Full-timeIndianapolis, IN, USAIn-person

About the Job

Requirements

  • A bachelor's degree in Life Sciences, Engineering, Chemistry, Pharmacy, or a related scientific discipline is required.
  • At least 8 years of progressive experience in pharmaceutical or biopharmaceutical Quality Assurance, including at least 4 years in non-conformance/deviation management, investigations, and/or CAPA program ownership.
  • At least 3 years of direct people management experience, including hiring, developing, and managing performance of quality professionals.
  • A demonstrated track record leading inspection-ready non-conformance/deviation and CAPA programs with measurable quality improvement outcomes is required.
  • Expert-level proficiency in structured root cause analysis methodologies, such as 5-Why, Fishbone, Fault Tree Analysis, Failure Mode and Effects Analysis, Apollo Root Cause Analysis, and Human Factors Analysis, and openness to applying other tools as appropriate.
  • Deep knowledge of current good manufacturing practice regulations and quality system frameworks, including FDA 21 CFR 210/211, ICH Q10, and EU GMP.
  • Demonstrated experience with electronic Quality Management Systems such as Veeva Vault, MasterControl, TrackWise, or equivalent.
  • Experience applying Lean, Six Sigma, or other operational excellence methodologies to quality system improvement initiatives.
  • Ability to author technically rigorous, audit-ready investigation reports and regulatory-facing documentation.
  • Ability to work in a GMP-regulated laboratory or manufacturing environment and use required personal protective equipment, including protective clothing, gloves, safety glasses, and radiation monitoring devices where applicable.
  • Ability to lift up to 25 pounds occasionally.

Responsibilities

  • Serve as the site subject-matter expert and authority for root cause analysis methodology, ensuring investigations reach defensible and systemic root causes.
  • Define, implement, and continuously improve the site's root cause analysis framework, including structured tools such as 5-Why Analysis, Ishikawa/Fishbone Diagrams, Fault Tree Analysis, Failure Mode and Effects Analysis, Is/Is Not Analysis, Apollo Root Cause Analysis, and Human Factors Analysis; evaluate and introduce other suitable methodologies.
  • Lead and facilitate deep-dive investigations for high-impact, high-risk, and repeat non-conformances and deviations, including events with potential regulatory, patient safety, or product quality implications.
  • Establish standards for investigation depth, scope determination, and evidence-gathering protocols.
  • Conduct cross-functional investigation reviews and challenge teams to eliminate assumption-based conclusions and reach data-supported root causes.
  • Ensure investigation reports are technically accurate, clear, audit-ready, and compliant with FDA, ICH Q10, and current good manufacturing practice expectations.
  • Lead retrospective reviews of closed investigations to assess the quality, consistency, and effectiveness of root cause determinations and corrective and preventive actions.
  • Oversee the non-conformance and deviation lifecycle from initiation and classification through investigation, corrective and preventive action assignment, effectiveness verification, and closure, ensuring timely completion against established metrics and regulatory commitments.
  • Champion adoption of data analytics and, where appropriate, artificial intelligence-enabled capabilities for the non-conformance and corrective and preventive action program, partnering with IT and Quality Systems teams as the business subject-matter expert and requirements owner.
  • Provide business requirements and investigative expertise to IT and Quality Systems teams evaluating tools for trend detection, deviation classification, and similarity or pattern identification across records.
  • Ensure deviation and non-conformance data in the site's electronic Quality Management System is clean, structured, and consistent to support reliable trending and analytics.
  • Develop and present data-driven quality metrics dashboards to site leadership, translating non-conformance and deviation trends and compliance key performance indicators into actionable insights.
  • Apply Lean and operational excellence principles to improve deviation and non-conformance management, eliminate waste, reduce investigation cycle time, and improve first-time quality of investigation outputs.
  • Use Lean tools including Value Stream Mapping to identify process bottlenecks, Plan-Do-Check-Act cycles for process improvement, Kaizen events for targeted improvements, Statistical Process Control and trend analysis to distinguish common-cause from special-cause variation, and mistake-proofing to reduce recurrence.
  • Lead regular deviation and non-conformance trend reviews and quality council presentations, translating data into systemic improvement initiatives.
  • Drive a proactive quality culture that shifts the site's approach from reactive investigation to predictive prevention.
  • Build and sustain a high-performing investigator team through direct coaching, structured development plans, and performance management.
  • Design, develop, and deliver site-wide root cause analysis and investigation training for staff ranging from shop-floor operators to quality and engineering professionals.
  • Establish investigation competency standards and certification pathways to ensure personnel demonstrate proficiency in root cause analysis tools and good manufacturing practice documentation requirements.
  • Ensure the site's non-conformance/deviation and corrective and preventive action programs remain inspection-ready and meet FDA, EMA, and other applicable regulatory expectations.
  • Lead preparation of non-conformance and deviation responses to regulatory agency inquiries, Warning Letters, and Form 483 observations.
  • Serve as a primary subject-matter expert and spokesperson on non-conformance, corrective and preventive action topics during regulatory audit and inspection readiness and conduct.
  • Maintain current knowledge of evolving regulatory expectations and industry guidance, including FDA 21 CFR Parts 210/211, ICH Q8, Q9, and Q10, EU GMP Annex 1, USP <1> and applicable monographs, and PDA Technical Reports.
  • Identify and communicate compliance risks and recommend mitigation strategies to Quality and Operations leadership.
  • Support critical investigations, audits, and compliance activities outside standard business hours as needed.

Desired Qualifications

  • Experience in biologics, cell and gene therapy, viral vector, or similar highly regulated biologics manufacturing environments is preferred.
  • Experience in radiopharmaceutical, aseptic fill/finish, or other sterile manufacturing environments is valued but not required.
  • Formal Lean or Six Sigma certification, such as Green Belt, Black Belt, or equivalent.
  • Familiarity with data analytics or artificial intelligence-supported quality tools in a GxP environment.
  • Experience leading or supporting FDA, EMA, or equivalent regulatory inspections as a subject-matter expert for non-conformances, deviations, and corrective and preventive actions.
  • Ability to apply artificial intelligence to improve team execution and decision-making.

About the Company

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Bristol Myers Squibb discovers, develops and sells prescription medicines for serious illnesses, including cancer, blood disorders, immune diseases and heart disease, for patients treated by doctors and hospitals around the world. Its best-known drug is Opdivo, an immunotherapy that helps the body's own immune system find and attack many kinds of cancer. Researchers develop drug candidates in its labs or bring them in through acquisitions and partnerships, then test them in clinical trials to win regulatory approval. The company makes and markets the approved medicines and earns its revenue from sales of patent-protected drugs. Its roots go back to a business founded in 1887, and it is based in Lawrence Township, New Jersey.

Company size
10,001+
Company stage
IPO
Headquarters
Lawrence Township, NJ
Founded
1887

Recently Posted Jobs

Explore more opportunities at Bristol Myers Squibb

See more jobs